Frequency of non-st elevation myocardial infarction in patient with normal electrocardiogram
Submission: 20 August 2025 | Acceptance: 25 September 2025 | Publication: 30 November 2025
1Anjli, 2Parshad, 3Dr Pardeep Sainani, 4Preeti batheja, 5Hafiz Syed Wahaj Azim Fatmi, 6Dr Ahsan Ali, 7Muhammad Nauman Khan
1Fcps trainee NICVD
2Fcps trainee LUHMHS Jamshoro
3Senior Registar, Nephrology, Bahria University of Medical Sciences, Karachi Campus
4Senior Registar, CTS, Bahria University of Medical Sciences, Karachi Campus
5Designation Consultant Cardiologist, HOD ICU, The Kidney Centre
6Senior Registrar, Cardiology, Bahria University of Medical Sciences, Karachi Campus
7Assistant Professor MBBS, FCPS (CRD), NICVD
Vol: 16/02. 321-238
Received: January 25, 2026 Accepted: March 02, 2026 Published: July 06, 2026
Abstract
Background: Non-ST elevation myocardial infarction (NSTEMI) may present without definitive electrocardiographic (ECG) abnormalities, posing a diagnostic challenge in emergency settings. Relying solely on ECG findings risks underdiagnosis of myocardial injury, particularly in patients with typical chest pain but normal ECG results.
Objective: To determine the frequency of NSTEMI in patients presenting with typical chest pain and normal electrocardiographic findings, using cardiac troponin I levels as the diagnostic standard.
Methods: This cross-sectional study was conducted at the National Institute of Cardiovascular Diseases (NICVD), Karachi, over a period of six months. A total of 271 patients aged 18–70 years presenting with chest pain and normal ECG were enrolled using consecutive sampling. Patients with prior myocardial infarction, coronary interventions, or chronic kidney disease were excluded. Blood samples were collected to evaluate troponin I levels. NSTEMI was diagnosed if troponin I exceeded >0.05 ng/dL for males and >0.03 ng/dL for females. Data were analyzed using SPSS version 23, with statistical significance set at p ≤ 0.05.
Results: Among the 271 patients, 168 (62%) were male, and the mean age was 47.8 ± 13.1 years. NSTEMI was diagnosed in 65 patients (24%), despite normal ECG findings. Higher NSTEMI frequencies were observed among diabetics (33%), hypertensives (28.4%), and urban residents (25.1%). The majority of patients with elevated troponin levels had no specific ECG changes at presentation.
Conclusion: A significant proportion of patients with chest pain and normal ECGs were diagnosed with NSTEMI, indicating that ECG alone is insufficient for ruling out myocardial infarction. Routine troponin testing is essential to prevent missed diagnoses and enable timely intervention.
Keywords: Acute Coronary Syndrome, Biomarkers, Chest Pain, Electrocardiography, Myocardial Infarction, NSTEMI, Troponin I
